Breaking News Instant updates and real-time market news.

FMC

FMC Corporation

$47.22

0.81 (1.75%)

07:10
10/19/16
10/19
07:10
10/19/16
07:10

FMC Corporation begins registration of new fungicide active ingredient

FMC Agricultural Solutions has begun the joint U.S. EPA and Canadian Pest Management Regulatory Agency registration process for bixafen, a new pyrazole carboxamide fungicide that belongs to a new generation of succinate dehydrogenase inhibitors. Registration is being sought for corn, soybeans, cereals, canola, peanuts and potatoes in the U.S. and, in some instances, Canada. FMC acquired exclusive rights to bixafen from Bayer CropScience to develop and distribute the novel product for row crops in the U.S. and Canada.

  • 03

    Nov

FMC FMC Corporation
$47.22

0.81 (1.75%)

04/14/16
LYON
04/14/16
INITIATION
Target $43
LYON
Outperform
FMC Corporation initiated with an Outperform at CLSA
Target $43.
04/21/16
FBCO
04/21/16
DOWNGRADE
Target $43
FBCO
Neutral
FMC Corporation downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analysts led by Christopher Parkinson downgraded FMC Corporation to Neutral and lowered its price target to $43 from $45. The believes channel inventories in the Americas are bloated and will take time to draw down and that the pricing environment will remain challenging through Q2 and Q3. Parkinson believes the recent rally in FMC shares reflect "euphoric" intermediate term expectations and are fully valued.
04/21/16
04/21/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Las Vegas Sands (LVS) downgraded to Neutral at JPMorgan by analyst Joseph Greff, who said the shares are likely to be range-bound until the Macau market shows signs of stabilization. He adds that the stock at current levels has "gotten ahead of itself" and expectations for improving Macau fundamentals. 2. Cummins (CMI) downgraded to Underperform from Neutral at Baird with analyst David Leiker citing stretched valuation and expects performance to remain under pressure from the challenging NAFTA Class 8 environment. 3. Knight Transportation (KNX) downgraded to Outperform at Raymond James based on less than 15% upside to the revised price target. It was also downgraded at Stifel due to the lower than expected Q1 EPS and the belief that the company did not show normal seasonal strength at the end of March. 4. Werner (WERN) downgraded to Hold at Stifel citing the company's Q1 EPS miss, soft pricing and a tough freight environment. 5. FMC Corporation (FMC) downgraded to Neutral at Credit Suisse by analyst Christopher Parkinson, who believes channel inventories in the Americas are bloated and will take time to draw down and that the pricing environment will remain challenging through Q2 and Q3. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/19/16
JEFF
05/19/16
NO CHANGE
Target $95
JEFF
Hold
Jefferies views Bayer buyout of Monsanto as 'relatively unlikely'
After Monsanto (MON) confirmed an unsolicited offer from Bayer (BAYRY), Jefferies analyst Laurence Alexander says he still believes a transaction is "relatively unlikely." The analyst expects Monsanto to object to Bayer's offer given its conviction in its research and development pipeline and longer-term competitive advantages. Shares of Syngenta (SYT) and DuPont (DD) could be pressured as regulatory scrutiny is likely to intensify should Monsanto get acquired, and BASF (BASFY) could sell off on investor concerns of a potential counter-bid, Alexander tells investors in a research note. On the other hand, he sees a potential Monsanto takeover as positive for shares of Novozymes (NVZMY) and FMC Corporation (FMC). "A further roll-up of 'specialty generic' agrichemical assets could entice capital, and FMC would be a plausible anchor for such an attempt," the analyst writes. He has a Hold rating on Monsanto with a $95 price target.

TODAY'S FREE FLY STORIES

FB

Facebook

$171.11

-1.06 (-0.62%)

07:26
09/22/17
09/22
07:26
09/22/17
07:26
Hot Stocks
Trump says Russia 'hoax' now onto Facebook ads »

President Donald Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

07:25
09/22/17
09/22
07:25
09/22/17
07:25
General news
FX Update: »

FX Update: USD-JPY dove…

JNJ

Johnson & Johnson

$131.75

-1.47 (-1.10%)

07:24
09/22/17
09/22
07:24
09/22/17
07:24
Conference/Events
FDA PDUFA Date for Janssen Biotech, a Johnson & Johnson company, Sirukumab »

Janssen Biotech, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 26

    Sep

  • 27

    Sep

  • 17

    Oct

KBH

KB Home

$20.78

0.07 (0.34%)

07:24
09/22/17
09/22
07:24
09/22/17
07:24
Recommendations
KB Home analyst commentary  »

KB Home forward estimates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

CUB

Cubic

$46.80

0.6 (1.30%)

07:23
09/22/17
09/22
07:23
09/22/17
07:23
Upgrade
Cubic rating change  »

Cubic upgraded to Strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$65.60

-0.19 (-0.29%)

07:21
09/22/17
09/22
07:21
09/22/17
07:21
Conference/Events
FDA PDUFA Date for Merck's sBLA for KEYTRUDA is September 22, 2017 »

Merck's anti-PD-1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 26

    Sep

  • 08

    Nov

  • 30

    Nov

GOOG

Alphabet

$932.45

0.87 (0.09%)

, GOOGL

Alphabet Class A

$947.55

0.01 (0.00%)

07:21
09/22/17
09/22
07:21
09/22/17
07:21
Periodicals
Google, partners to issue refunds to advertisers over fake traffic, WSJ reports »

Google is planning to…

GOOG

Alphabet

$932.45

0.87 (0.09%)

GOOGL

Alphabet Class A

$947.55

0.01 (0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

  • 29

    Nov

JNJ

Johnson & Johnson

$131.75

-1.47 (-1.10%)

07:21
09/22/17
09/22
07:21
09/22/17
07:21
Recommendations
Johnson & Johnson analyst commentary  »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 26

    Sep

  • 27

    Sep

  • 17

    Oct

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

, VSAR

Versartis

$21.60

-0.25 (-1.14%)

07:18
09/22/17
09/22
07:18
09/22/17
07:18
Recommendations
Ascendis Pharma, Versartis analyst commentary  »

Ascendis Pharma price…

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

VSAR

Versartis

$21.60

-0.25 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MA

MasterCard

$141.72

-0.52 (-0.37%)

07:17
09/22/17
09/22
07:17
09/22/17
07:17
Recommendations
MasterCard analyst commentary  »

MasterCard price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

BP

BP

$37.70

0.47 (1.26%)

, SLB

Schlumberger

$68.09

0.47 (0.70%)

07:17
09/22/17
09/22
07:17
09/22/17
07:17
Conference/Events
Federal Reserve Banks of Dallas and Kansas City hold a conference »

2017 Energy Conference:…

BP

BP

$37.70

0.47 (1.26%)

SLB

Schlumberger

$68.09

0.47 (0.70%)

GS

Goldman Sachs

$231.29

1.5 (0.65%)

PAA

Plains All American

$21.72

-0.33 (-1.50%)

CLR

Continental Resources

$37.66

-0.15 (-0.40%)

CHK

Chesapeake

$4.17

-0.02 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

  • 02

    Oct

  • 03

    Oct

  • 17

    Oct

  • 20

    Oct

  • 22

    Oct

  • 08

    Nov

GOOG

Alphabet

$932.45

0.87 (0.09%)

, GOOGL

Alphabet Class A

$947.55

0.01 (0.00%)

07:14
09/22/17
09/22
07:14
09/22/17
07:14
Periodicals
Google had planned a multimillion Garden Bridge donation, FT says »

Google (GOOG, GOOGL) was…

GOOG

Alphabet

$932.45

0.87 (0.09%)

GOOGL

Alphabet Class A

$947.55

0.01 (0.00%)

AAPL

Apple

$153.39

-2.68 (-1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

  • 29

    Nov

VCRA

Vocera

$29.59

0.42 (1.44%)

07:12
09/22/17
09/22
07:12
09/22/17
07:12
Recommendations
Vocera analyst commentary  »

Vocera checks show…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

XPER

Xperi

$24.75

-0.05 (-0.20%)

07:11
09/22/17
09/22
07:11
09/22/17
07:11
Conference/Events
Xperi management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WMC

Western Asset Mortgage

$10.66

0.11 (1.04%)

07:10
09/22/17
09/22
07:10
09/22/17
07:10
Conference/Events
Western Asset Mortgage management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

VERI

Veritone

$53.70

7.57 (16.41%)

07:09
09/22/17
09/22
07:09
09/22/17
07:09
Conference/Events
Veritone management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 16

    Nov

EFX

Equifax

$98.25

2.25 (2.34%)

07:09
09/22/17
09/22
07:09
09/22/17
07:09
Upgrade
Equifax rating change  »

Equifax upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

FINL

Finish Line

$9.22

-0.21 (-2.23%)

, SPLS

Staples

07:08
09/22/17
09/22
07:08
09/22/17
07:08
Hot Stocks
Finish Line names Staples CTO Faisal Masud to board »

The Finish Line (FINL)…

FINL

Finish Line

$9.22

-0.21 (-2.23%)

SPLS

Staples

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 29

    Nov

SMHI

SLM Holdings

$12.32

-0.2 (-1.60%)

07:08
09/22/17
09/22
07:08
09/22/17
07:08
Conference/Events
SLM Holdings management to meet with Evercore ISI »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

FINL

Finish Line

$9.22

-0.21 (-2.23%)

07:07
09/22/17
09/22
07:07
09/22/17
07:07
Hot Stocks
Breaking Hot Stocks news story on Finish Line »

Finish Line CEO: Planning…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

FINL

Finish Line

$9.22

-0.21 (-2.23%)

07:06
09/22/17
09/22
07:06
09/22/17
07:06
Earnings
Finish Line sees Q4 adjusted EPS 50c-58c, SSS down 3%-5% »

For the fourth quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

FINL

Finish Line

$9.22

-0.21 (-2.23%)

07:06
09/22/17
09/22
07:06
09/22/17
07:06
Earnings
Finish Line sees Q3 adjusted EPS (40c)-(32c), consensus (35c) »

Sees Q3 Finish Line…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

SIVB

SVB Financial

$179.06

1.84 (1.04%)

07:05
09/22/17
09/22
07:05
09/22/17
07:05
Conference/Events
SVB Financial management to meet with Piper Jaffray »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 22

    Oct

FINL

Finish Line

$9.22

-0.21 (-2.23%)

07:05
09/22/17
09/22
07:05
09/22/17
07:05
Earnings
Finish Line sees FY18 adjusted EPS 50c-60c, consensus 57c »

The company's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

PG

Procter & Gamble

$92.64

-1.76 (-1.86%)

07:05
09/22/17
09/22
07:05
09/22/17
07:05
Hot Stocks
Procter & Gamble responds to Glass Lewis report »

The Procter & Gamble…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.